{"id":598533,"date":"2025-11-28T04:37:20","date_gmt":"2025-11-28T04:37:20","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/598533\/"},"modified":"2025-11-28T04:37:20","modified_gmt":"2025-11-28T04:37:20","slug":"determining-the-value-of-genomics-in-healthcare","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/598533\/","title":{"rendered":"Determining the value of genomics in healthcare"},"content":{"rendered":"
  • \n

    Stark, Z. et al. Integrating genomics into healthcare: a global responsibility. Am. J. Hum. Genet 104<\/b>, 13\u201320 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sheikh Hassani, M. et al. Virtual gene panels have a superior diagnostic yield for inherited rare diseases relative to static panels. Clin. Chem. 71<\/b>, 169\u2013184 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wojcik, M. H. et al. Genome sequencing for diagnosing rare diseases. N. Engl. J. Med. 390<\/b>, 1985\u20131997 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Dai, P. et al. Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: a systematic review and meta-analysis. Genet. Med. 24<\/b>, 1618\u20131629 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Martyn, M. et al. Offering complex genomic screening in acute pediatric settings: Family decision-making and outcomes. Genet. Med. 27<\/b>, 101327 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Leong, I. U. S. et al. Large-scale pharmacogenomics analysis of patients with cancer within the 100,000 Genomes Project combining whole-genome sequencing and medical records to inform clinical practice. J. Clin. Oncol. 43<\/b>, 682\u2013693 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chen, Y. et al. De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome. Nature 632<\/b>, 832\u2013840 (2024).<\/p>\n<\/li>\n

  • \n

    Clark, M. M. et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom. Med. 3<\/b>, 16 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kohler, J. N., Turbitt, E. & Biesecker, B. B. Personal utility in genomic testing: a systematic literature review. Eur. J. Hum. Genet 25<\/b>, 662\u2013668 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S. et al. Clinical genomic testing: what matters to key stakeholders?. Eur. J. Hum. Genet. 28<\/b>, 866\u2013873 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pollard, S. et al. Toward the diagnosis of rare childhood genetic diseases: what do parents value most?. Eur. J. Hum. Genet. 29<\/b>, 1491\u20131501 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Conceptualization of utility in translational clinical genomics research. Am. J. Hum. Genet. 108<\/b>, 2027\u20132036 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research. Eur. J. Hum. Genet. 31<\/b>, 445\u2013452 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet. Med. 17<\/b>, 505\u2013507 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Norris, S., Belcher, A., Howard, K. & Ward, R. L. Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments. J. Community Genet. 13<\/b>, 503\u2013522 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ellard, S. et al. Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access. J. Med. Genet. 61<\/b>, 1103\u20131112 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Expert Meeting on Accelerating Access to Human Genomics for Public Health Participants. Accelerating access to human genomics for public health: perspectives from the Western Pacific region. Lancet Reg. Health West Pac. 53<\/b>, 101265 (2024).<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wu, Y. et al. Parental health spillover effects of paediatric rare genetic conditions. Qual. Life Res. 29<\/b>, 2445\u20132454 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    National Institute for Health and Care Excellence. Modular update to NICE manuals: health inequalities. https:\/\/www.nice.org.uk\/process\/pmg36\/documents\/supporting-documentation-3<\/a> (2025).<\/p>\n<\/li>\n

  • \n

    Hayeems, R. Z. et al. Clinical utility of genomic sequencing: a measurement toolkit. NPJ Genom. Med. 5<\/b>, 56 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mallett, A., Stark, Z., Fehlberg, Z., Best, S. & Goranitis, I. Determining the utility of diagnostic genomics: a conceptual framework. Hum. Genomics 17<\/b>, 75 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chung, C. C. Y., Chu, A. T .W. & Chung, B. H. Y. A roadmap for genome projects to foster psychosocial and economic evidence to further policy and practice. Commun. Med. 5<\/b>, 198 (2025).<\/p>\n<\/li>\n

  • \n

    Hartley, T. et al. Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: a prospective cohort study. Genet. Med. 26<\/b>, 101012 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Australian Genomics Health Alliance Acute Care Flagship; Lunke, S. et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian Public Health Care System. JAMA 323<\/b>, 2503\u20132511 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Lunke, S. et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat. Med. 29<\/b>, 1681\u20131691 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Dimmock, D. et al. Project Baby Bear: rapid precision care incorporating rWGS in 5 California children\u2019s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am. J. Hum. Genet. 108<\/b>, 1231\u20131238 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Grant, P. E., Pampaka, M., Payne, K., Clarke, A. & McAllister, M. Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale. Eur. J. Med Genet. 62<\/b>, 324\u2013334 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stark, Z. et al. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Genet. Med. 21<\/b>, 173\u2013180 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Khoury, M. J. et al. Health equity in the implementation of genomics and precision medicine: a public health imperative. Genet. Med. 24<\/b>, 1630\u20131639 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    McAllister, M., Wood, A. M., Dunn, G., Shiloh, S. & Todd, C. The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin. Genet. 79<\/b>, 413\u2013424 (2011).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature. Genet. Med. 21<\/b>, 3\u201316 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pan, T., Wu, Y., Buchanan, J. & Goranitis, I. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia. Health Qual. Life Outcomes 21<\/b>, 132 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hayeems, R. Z. et al. The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing. Genet. Med. 22<\/b>, 95\u2013101 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hayeems, R. Z. et al. The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): preliminary evidence of validity and reliability. Genet. Med. 24<\/b>, 430\u2013438 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hayeems, R. Z. et al. Assessing the performance of the Clinician-reported Genetic Testing Utility InDEx (C-GUIDE): further evidence of inter-rater reliability. Clin. Ther. 45<\/b>, 729\u2013735 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hayeems, R. Z. et al. Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity. Eur. J. Hum. Genet. 30<\/b>, 1423\u20131431 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hayeems, R. Z. et al. The Clinician-reported Genetic Testing Utility InDEx (C-GUIDE) for Prenatal Care: initial evidence of content and construct validity. Genet. Med. 27<\/b>, 101306 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Dolman, L. I. et al. The Clinician-reported Genetic Testing Utility InDEx for Neonatal Intensive Care (C-GUIDE NICU): quantifying genome-wide sequencing utility in the NICU. Genet. Med. 27<\/b>, 101503 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Perceived utility of genomic sequencing: qualitative analysis and synthesis of a conceptual model to inform patient-centered instrument development. Patient 15<\/b>, 317\u2013328 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for pediatric diagnostic testing. Genet. Med. 26<\/b>, 101146 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for adult screening. Genet. Med. 26<\/b>, 101240 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Turbitt, E. et al. The PrU: development and validation of a measure to assess personal utility of genomic results. Genet. Med. 25<\/b>, 100356 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Turbitt, E. et al. The Parent PrU: a measure to assess personal utility of pediatric genomic results. Genet. Med. 26<\/b>, 100994 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fehlberg, Z., Goranitis, I., Mallett, A. J., Stark, Z. & Best, S. Determining priority indicators of utility for genomic testing in rare disease: a Delphi study. Genet. Med. 26<\/b>, 101116 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Goranitis, I. et al. A standardized measurement and valuation scale of genomic utility for policy decisions: The GUV Scale. Value Health 28<\/b>, 184\u2013190 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Phillips, K. A. et al. Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions. Value Health 21<\/b>, 1033\u20131042 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Grosse, S. D. & Khoury, M. J. What is the clinical utility of genetic testing?. Genet. Med. 8<\/b>, 448\u2013450 (2006).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Grosse, S. D., Wordsworth, S. & Payne, K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet. Med. 10<\/b>, 648\u2013654 (2008).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Regier, D. A., Friedman, J. M., Makela, N., Ryan, M. & Marra, C. A. Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clin. Genet. 75<\/b>, 514\u2013521 (2009).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Regier, D. A., Ryan, M., Phimister, E. & Marra, C. A. Bayesian and classical estimation of mixed logit: an application to genetic testing. J. Health Econ. 28<\/b>, 598\u2013610 (2009).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ho, M. et al. A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies. Value Health 19<\/b>, 746\u2013750 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bridges, J. F. P. et al. A roadmap for increasing the usefulness and impact of patient-preference studies in decision making in health: a good practices report of an ISPOR task force. Value Health 26<\/b>, 153\u2013162 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Approaches to incorporation of preferences into health economic models of genomic medicine: a critical interpretive synthesis and conceptual framework. Appl. Health Econ. Health Policy 23<\/b>, 337\u2013358 (2025).<\/p>\n<\/li>\n

  • \n

    Strauss, K. A. et al. Genomic diagnostics within a medically underserved population: efficacy and implications. Genet. Med. 20<\/b>, 31\u201341 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Marshall, D. A. et al. The value of diagnostic testing for parents of children with rare genetic diseases. Genet. Med. 21<\/b>, 2798\u20132806 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Meng, Y., Clarke, P. M. & Goranitis, I. The value of genomic testing: a contingent valuation across six child- and adult-onset genetic conditions. Pharmacoeconomics 40<\/b>, 215\u2013223 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Goranitis, I., Best, S., Christodoulou, J., Stark, Z. & Boughtwood, T. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments. Genet. Med. 22<\/b>, 1311\u20131319 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Goranitis, I., Best, S., Stark, Z., Boughtwood, T. & Christodoulou, J. The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment. Genet. Med. 23<\/b>, 155\u2013162 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Goranitis, I., Best, S., Christodoulou, J., Boughtwood, T. & Stark, Z. Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment. Eur. J. Hum. Genet. 29<\/b>, 1645\u20131653 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Meng, Y. et al. The value of genomic testing in severe childhood speech disorders. Eur. J. Hum. Genet. 32<\/b>, 440\u2013447 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Regier, D. A., Weymann, D., Buchanan, J., Marshall, D. A. & Wordsworth, S. Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions. Value Health 21<\/b>, 1043\u20131047 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Peters, R. et al. Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia. Am. J. Hum. Genet. 112<\/b>, 1515\u20131527 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Regier, D. A., Friedman, J. M. & Marra, C. A. Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am. J. Hum. Genet. 86<\/b>, 765\u2013772 (2010).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Goranitis, I. et al. Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children. Genet. Med. 24<\/b>, 1037\u20131044 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wu, Y. et al. Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation. Eur. J. Hum. Genet. 30<\/b>, 577\u2013586 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Downie, L. et al. Exome sequencing for isolated congenital hearing loss: a cost-effectiveness analysis. Laryngoscope 131<\/b>, E2371\u2013E2377 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jayasinghe, K. et al. Cost-effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases. Kidney Int. Rep. 6<\/b>, 2850\u20132861 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    O\u2019Rourke, B., Oortwijn, W. Schuller, T. & International Joint Task Group The new definition of health technology assessment:a milestone in international collaboration. Int. J. Technol. Assess. Health Care 36<\/b>, 187\u2013190 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Group, N. I. S. et al. Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial. JAMA Pediatr. 175<\/b>, 1218\u20131226 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kingsmore, S. F. et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am. J. Hum. Genet. 105<\/b>, 719\u2013733 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Dimmock, D. P. et al. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm. Am. J. Hum. Genet. 107<\/b>, 942\u2013952 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Petrikin, J. E. et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genom. Med. 3<\/b>, 6 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Le Tourneau, C. et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 16<\/b>, 1324\u20131334 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ceyhan-Birsoy, O. et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project. Am. J. Hum. Genet. 104<\/b>, 76\u201393 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Gibbs, S. N. et al. Comprehensive review on the clinical impact of next-generation sequencing tests for the management of advanced cancer. JCO Precis. Oncol. 7<\/b>, e2200715 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stark, Z. et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet. Med. 19<\/b>, 867\u2013874 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tan, T. Y. et al. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. Eur. J. Hum. Genet. 27<\/b>, 1791\u20131799 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tuxen, I. V. et al. Copenhagen Prospective Personalized Oncology (CoPPO)-clinical utility of using molecular profiling to select patients to phase I trials. Clin. Cancer Res. 25<\/b>, 1239\u20131247 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Von Hoff, D. D. et al. Pilot study using molecular profiling of patients\u2019 tumors to find potential targets and select treatments for their refractory cancers. J. Clin. Oncol. 28<\/b>, 4877\u20134883 (2010).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Weymann, D. et al. Clinical and cost outcomes following genomics-informed treatment for advanced cancers. Cancer Med. 10<\/b>, 5131\u20135140 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Vissers, L. et al. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet. Med. 19<\/b>, 1055\u20131063 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yeung, A. et al. A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients. Genet. Med. 22<\/b>, 1986\u20131993 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Weymann, D. et al. Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care. J. Community Genet. 13<\/b>, 523\u2013538 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hernando-Calvo, A. et al. Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data. EClinicalMedicine 69<\/b>, 102443 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Krebs, E. et al. Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based study. Lancet Reg. Health Am. 40<\/b>, 100936 (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chung, C. C. Y. et al. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations. Genet. Med. 25<\/b>, 100896 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Shickh, S., Mighton, C., Uleryk, E., Pechlivanoglou, P. & Bombard, Y. The clinical utility of exome and genome sequencing across clinical indications: a systematic review. Hum. Genet. 140<\/b>, 1403\u20131416 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kobayashi, E. S. et al. Long term follow up of children who received rapid genomic sequencing. Genet. Med. 27<\/b>, 101403 (2025).<\/p>\n<\/li>\n

  • \n

    Payne, K., Gavan, S. P., Wright, S. J. & Thompson, A. J. Cost-effectiveness analyses of genetic and genomic diagnostic tests. Nat. Rev. Genet. 19<\/b>, 235\u2013246 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Schwarze, K., Buchanan, J., Taylor, J. C. & Wordsworth, S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet. Med. 20<\/b>, 1122\u20131130 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Grosse, S. D. & Gudgeon, J. M. Cost or price of sequencing? Implications for economic evaluations in genomic medicine. Genet. Med. 23<\/b>, 1833\u20131835 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Santos Gonzalez, F. et al. Microcosting diagnostic genomic sequencing: a systematic review. Genet. Med. 25<\/b>, 100829 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fahr, P., Buchanan, J. & Wordsworth, S. A review of health economic studies comparing traditional and massively parallel sequencing diagnostic pathways for suspected genetic disorders. Pharmacoeconomics 38<\/b>, 143\u2013158 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Santos Gonzalez, F. et al. Microcosting genomics: challenges and opportunities. Genet. Med. 27<\/b>, 101310 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bourke, M. et al. The cost-effectiveness of genomic medicine in cancer control: a systematic literature review. Appl. Health Econ. Health Policy 23<\/b>, 359\u2013393 (2025).<\/p>\n<\/li>\n

  • \n

    Regier, D. A. et al. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada. NPJ Precis. Oncol. 6<\/b>, 76 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Schmidtke, J. & Cassiman, J. J. The EuroGentest clinical utility gene cards. Eur. J. Hum. Genet. 18<\/b>, 1068 (2010).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Burke, W. et al. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am. J. Epidemiol. 156<\/b>, 311\u2013318 (2002).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Schilling, C. et al. Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014-2023. Eur. J. Hum. Genet. 33<\/b>, 1044\u20131050 (2025).<\/p>\n<\/li>\n

  • \n

    Mordaunt, D. A., Dalziel, K., Goranitis, I. & Stark, Z. Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia. Eur. J. Hum. Genet 31<\/b>, 977\u2013979 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Douglas, M. P., Parker, S. L., Trosman, J. R., Slavotinek, A. M. & Phillips, K. A. Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited. Genet. Med. 21<\/b>, 152\u2013160 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Trosman, J. R. et al. Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS). Genet. Med. 22<\/b>, 283\u2013291 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S. et al. Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics. Genet. Med. 23<\/b>, 950\u2013955 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Zion, T. N. et al. Insurance denials and diagnostic rates in a pediatric genomic research cohort. Genet. Med. 25<\/b>, 100020 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Lu, C. Y. et al. Insurance coverage policies for pharmacogenomic and multi-gene testing for cancer. J. Pers. Med. 8<\/b>, 19 (2018).<\/p>\n<\/li>\n

  • \n

    Beinfeld, M. T., Rucker, J. A., Jenkins, N. B., de Breed, L. A. & Chambers, J. D. Variation in Medicaid and commercial coverage of cell and gene therapies. Health Policy Open 5<\/b>, 100103 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Phillips, K. A. et al. US private payers\u2019 perspectives on insurance coverage for genome sequencing versus exome sequencing: a study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER). Genet. Med. 24<\/b>, 238\u2013244 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, H. S., Sherman, M. & Cardeiro, D. Conversations with the editors: stewardship in genomic medicine-insights from health care payers at the forefront of clinical innovation and partnerships. Clin. Ther. 45<\/b>, 690\u2013694 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wiedower, J. et al. Payer perspectives on genomic testing in the United States: a systematic literature review. Genet. Med. 27<\/b>, 101329 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Braithwaite, J., Churruca, K., Long, J. C., Ellis, L. A. & Herkes, J. When complexity science meets implementation science: a theoretical and empirical analysis of systems change. BMC Med. 16<\/b>, 63 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Zebrowski, A. M. et al. Qualitative study of system-level factors related to genomic implementation. Genet. Med. 21<\/b>, 1534\u20131540 (2019).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S., Long, J. C., Gaff, C., Braithwaite, J. & Taylor, N. Investigating the adoption of clinical genomics in Australia. An Implementation Science case study. Genes 12<\/b>, 317 (2021).<\/p>\n<\/li>\n

  • \n

    Gaff, C. L. et al. Preparing for genomic medicine: a real world demonstration of health system change. NPJ Genom. Med. 2<\/b>, 16 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S., Long, J. C., Gaff, C., Braithwaite, J. & Taylor, N. Organizational perspectives on implementing complex health interventions: clinical genomics in Australia. J. Health Organ. Manag. 35<\/b>, 825\u2013845 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stark, Z. et al. Australian genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. Am. J. Hum. Genet. 110<\/b>, 419\u2013426 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Braithwaite, J., Glasziou, P. & Westbrook, J. The three numbers you need to know about healthcare: the 60-30-10 challenge. BMC Med. 18<\/b>, 102 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Khorshidi, H. A., Marshall, D., Goranitis, I., Schroeder, B. & IJzerman, M. System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model. Expert Rev. Pharmacoecon. Outcomes Res. 24<\/b>, 37\u201347 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Investigators, G. P. P. et al. 100,000 genomes pilot on rare-disease diagnosis in health care – preliminary report. N. Engl. J. Med. 385<\/b>, 1868\u20131880 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sosinsky, A. et al. Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. Nat. Med. 30<\/b>, 279\u2013289 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Howley, C. et al. The expanding global genomics landscape: converging priorities from national genomics programs. Am. J. Hum. Genet. 112<\/b>, 751\u2013763 (2025).<\/p>\n<\/li>\n

  • \n

    Stark, Z. et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet. Med. 18<\/b>, 1090\u20131096 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Lionel, A. C. et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med. 20<\/b>, 435\u2013443 (2018).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Regier, D. A. et al. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: evidence from Canada. Genet. Med. 26<\/b>, 101069 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Dragojlovic, N. et al. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet. Med. 22<\/b>, 1437\u20131449 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jenkins, B. D. et al. The 2019 US medical genetics workforce: a focus on clinical genetics. Genet. Med. 23<\/b>, 1458\u20131464 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jayasinghe, K. et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet. Med. 23<\/b>, 183\u2013191 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yanes, T. et al. Evaluation and pilot testing of a multidisciplinary model of care to mainstream genomic testing for paediatric inborn errors of immunity. Eur. J. Hum. Genet 31<\/b>, 1125\u20131132 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ma, A. et al. Genomic multidisciplinary teams: a model for navigating genetic mainstreaming and precision medicine. J. Paediatr. Child Health 60<\/b>, 118\u2013124 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    McCorkell, G. et al. A national education program for rapid genomics in pediatric acute care: Building workforce confidence, competence, and capability. Genet. Med. 26<\/b>, 101224 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nisselle, A., Terrill, B., Janinski, M., Metcalfe, S. & Gaff, C. Ensuring best practice in genomics education: a scoping review of genomics education needs assessments and evaluations. Am. J. Hum. Genet. 111<\/b>, 1508\u20131523 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nisselle, A. et al. Ensuring best practice in genomics education: a theory- and empirically informed evaluation framework. Am. J. Hum. Genet. 111<\/b>, 1497\u20131507 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nightingale, K. P. et al. Evaluation of the Master\u2019s in Genomic Medicine framework: a national, multiprofessional program to educate health care professionals in NHS England. Genet. Med. 27<\/b>, 101277 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pichini, A. & Bishop, M. A nationally agreed cross-professional competency framework to facilitate genomic testing. Genet. Med. 24<\/b>, 1743\u20131752 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pichini, A., Tatton-Brown, K., Thomas, E. & Bishop, M. A cross-professional competency framework for communicating genomic results. J. Genet. Couns. 33<\/b>, 222\u2013231 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Karthikeyan, A., McKee, S. & McKay, G. J. Integration of genomic medicine to mainstream patient care within the UK National Health Service. Ulster Med. J. 93<\/b>, 111\u2013118 (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Berkman, J. et al. Mainstreaming cancer genomic testing: a scoping review of the acceptability, efficacy, and impact. Clin. Genet. 107<\/b>, 123\u2013135 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mackley, M. P. et al. Mainstreaming of clinical genetic testing: a conceptual framework. Genet. Med. 27<\/b>, 101465 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mordaunt, D. A. et al. The cost of proband and trio exome and genome analysis in rare disease: a micro-costing study. Genet. Med. 26<\/b>, 101058 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S. et al. Teamwork in clinical genomics: a dynamic sociotechnical healthcare setting. J. Eval. Clin. Pract. 27<\/b>, 1369\u20131380 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S. et al. The leadership behaviors needed to implement clinical genomics at scale: a qualitative study. Genet. Med. 22<\/b>, 1384\u20131390 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Friedrich, B. et al. A very big challenge\u201d: a qualitative study to explore the early barriers and enablers to implementing a national genomic medicine service in England. Front. Genet. 14<\/b>, 1282034 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kirk, E. P. et al. Nationwide, couple-based genetic carrier screening. N. Engl. J. Med. 391<\/b>, 1877\u20131889 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Casalino, S. et al. Genome screening, reporting, and genetic counseling for healthy populations. Hum. Genet. 142<\/b>, 181\u2013192 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stark, Z. & Scott, R. H. Genomic newborn screening for rare diseases. Nat. Rev. Genet. 24<\/b>, 755\u2013766 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    McDermott, J. H., Tsakiroglou, M., Newman, W. G. & Pirmohamed, M. Pharmacogenomics in the UK National Health Service: progress towards implementation. Br. J. Clin. Pharmacol. 91<\/b>, 2241\u20132250 (2025).<\/p>\n<\/li>\n

  • \n

    Lennon, N. J. et al. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. Nat. Med. 30<\/b>, 480\u2013487 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Rehm, H. L. et al. ClinGen\u2013the Clinical Genome Resource. N. Engl. J. Med. 372<\/b>, 2235\u20132242 (2015).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Rehm, H. L., Harrison, S. M. & Martin, C. L. ClinVar is a critical resource to advance variant interpretation. Oncologist 22<\/b>, 1562 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tudini, E. et al. Shariant platform: enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. Am. J. Hum. Genet 109<\/b>, 1960\u20131973 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stark, Z. et al. Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am. J. Hum. Genet. 108<\/b>, 1551\u20131557 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    DiStefano, M. T. et al. The Gene Curation Coalition: a global effort to harmonize gene-disease evidence resources. Genet. Med. 24<\/b>, 1732\u20131742 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Stark, Z. et al. A call to action to scale up research and clinical genomic data sharing. Nat. Rev. Genet. 26<\/b>, 141\u2013147 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Rehm, H. L. et al. GA4GH: international policies and standards for data sharing across genomic research and healthcare. Cell. Genom. 1<\/b>, 100029 (2021).<\/p>\n<\/li>\n

  • \n

    Roberts, M. C., Kennedy, A. E., Chambers, D. A. & Khoury, M. J. The current state of implementation science in genomic medicine: opportunities for improvement. Genet. Med. 19<\/b>, 858\u2013863 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chambers, D. A., Feero, W. G. & Khoury, M. J. Convergence of implementation science, precision medicine, and the learning health care system: a new model for biomedical research. JAMA 315<\/b>, 1941\u20131942 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Moullin, J. C. et al. Ten recommendations for using implementation frameworks in research and practice. Implement. Sci. Commun. 1<\/b>, 42 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Brown, H. L., Sherburn, I. A., Gaff, C., Taylor, N. & Best, S. Structured approaches to implementation of clinical genomics: a scoping review. Genet Med 24<\/b>, 1415\u20131424 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M. & Stetler, C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med. Care 50<\/b>, 217\u2013226 (2012).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Taylor, N. et al. Aligning intuition and theory: a novel approach to identifying the determinants of behaviours necessary to support implementation of evidence into practice. Implement. Sci. 18<\/b>, 29 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S. et al. Learning from scaling up ultra-rapid genomic testing for critically ill children to a national level. NPJ Genom. Med. 6<\/b>, 5 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Cheng, L. et al. Optimising the mainstreaming of renal genomics: Complementing empirical and theoretical strategies for implementation. Eur. J. Hum. Genet. 33<\/b>, 351\u2013359 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S. et al. Using a theory informed approach to design, execute, and evaluate implementation strategies to support offering reproductive genetic carrier screening in Australia. BMC Health Serv. Res. 23<\/b>, 1276 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fehlberg, Z. et al. Scaling-up and future sustainability of a national reproductive genetic carrier screening program. NPJ Genom. Med. 8<\/b>, 18 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S., Long, J. C., Braithwaite, J. & Taylor, N. Standardizing variation: Scaling up clinical genomics in Australia. Genet. Med. 25<\/b>, 100109 (2023).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Laskowski, N. M. et al. Variation exists in service delivery: similarities and differences in the provision of a whole genome sequencing service for paediatric rare disease patients in the National Health Service in England. Public Health Genomics 28<\/b>, 1\u201318 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Best, S., Vidic, N., An, K., Collins, F. & White, S. M. A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease. Eur. J. Hum. Genet. 30<\/b>, 645\u2013652 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Casauria, S. et al. Assessing the unmet needs of genomic testing in Australia: a geospatial exploration. Eur. J. Hum. Genet. 33, 496\u2013503 (2024).<\/p>\n<\/li>\n

  • \n

    Pichler, F. B. et al. An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report. Int. J. Technol. Assess. Health Care 40<\/b>, e45 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Makady, A., de Boer, A., Hillege, H., Klungel, O. & Goettsch, W. What is real-world data? A review of definitions based on literature and stakeholder interviews. Value Health 20<\/b>, 858\u2013865 (2017).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sterrantino, A. F. Observational studies: practical tips for avoiding common statistical pitfalls. Lancet Reg. Health Southeast Asia 25<\/b>, 100415 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Weymann, D., Krebs, E. & Regier, D. A. Addressing immortal time bias in precision medicine: practical guidance and methods development. Health Serv. Res. 60<\/b>, e14376 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hernan, M. A., Sauer, B. C., Hernandez-Diaz, S., Platt, R. & Shrier, I. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J. Clin. Epidemiol. 79<\/b>, 70\u201375 (2016).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pollard, S. et al. Defining a core data set for the economic evaluation of precision oncology. Value Health 25<\/b>, 1371\u20131380 (2022).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    McPhail, M., McCabe, C., Regier, D. A. & Bubela, T. The importance of and challenges with adopting life-cycle regulation and reimbursement in Canada. Health. Policy 17<\/b>, 81\u201390 (2022).<\/p>\n


    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Maggio, L. A., Villalba, K., German, D., Kanter, S. L. & Collard, H. R. Defining the learning health care system: an international health system leadership perspective. Acad. Med. 99<\/b>, 215\u2013220 (2024).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Meghea, C. I. et al. An NIH investment in health equity – the economic impact of the Flint Center for Health Equity Solutions. BMC Public Health 21<\/b>, 1774 (2021).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hock, D. H. et al. Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases. Genome Med. 17<\/b>, 58 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tambuyzer, E. et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat. Rev. Drug Discov. 19<\/b>, 93\u2013111 (2020).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chung, C. C. Y., Chu, A. T. W. & Chung, B. H. Y. A roadmap for genome projects to foster psychosocial and economic evidence to further policy and practice. Commun. Med. 5<\/b>, 198 (2025).<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n","protected":false},"excerpt":{"rendered":"Stark, Z. et al. Integrating genomics into healthcare: a global responsibility. Am. J. Hum. Genet 104, 13\u201320 (2019).…\n","protected":false},"author":2,"featured_media":598534,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[3967,3970,36915,3968,105,21372,15612,4348,6552,19313,19314,19315,16,15],"class_list":{"0":"post-598533","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-biomedicine","9":"tag-cancer-research","10":"tag-clinical-genetics","11":"tag-general","12":"tag-health","13":"tag-health-care-economics","14":"tag-health-policy","15":"tag-healthcare","16":"tag-infectious-diseases","17":"tag-metabolic-diseases","18":"tag-molecular-medicine","19":"tag-neurosciences","20":"tag-uk","21":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115625475793292967","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/598533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=598533"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/598533\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/598534"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=598533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=598533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=598533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}